Connection

Pierachille Santus to Bronchodilator Agents

Back to Details
This is a "connection" page, showing publications Pierachille Santus has written about Bronchodilator Agents.
Pierachille Santus
Connection Strength
1.159
Bronchodilator Agents
  1. Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD. Pharmacol Res. 2018 07; 133:160-169.
    View in: PubMed
    Score: 0.486
  2. Early management of COPD: where are we now and where do we go from here? A Delphi consensus project. Int J Chron Obstruct Pulmon Dis. 2019; 14:353-360.
    View in: PubMed
    Score: 0.128
  3. Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis. Respir Res. 2018 01 24; 19(1):18.
    View in: PubMed
    Score: 0.119
  4. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine. COPD. 2017 Dec; 14(6):641-647.
    View in: PubMed
    Score: 0.117
  5. Acute effects of long-acting bronchodilators on small airways detected in COPD patients by single-breath N2 test and lung P-V curve. J Appl Physiol (1985). 2017 Nov 01; 123(5):1266-1275.
    View in: PubMed
    Score: 0.115
  6. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Respir Med. 2017 04; 125:49-56.
    View in: PubMed
    Score: 0.112
  7. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. Respir Med. 2006 Jul; 100(7):1277-81.
    View in: PubMed
    Score: 0.051
  8. Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide. Int J Chron Obstruct Pulmon Dis. 2018; 13:2319-2333.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.